Skip to main content

From Peripheralized to Cell- and Organelle-Targeted Medicine: The 3rd Generation of Cannabinoid-1 Receptor Antagonists for the Treatment of Chronic Kidney Disease

Publications

Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy

Author(s): Liad Hinden, Shiran Udi, Adi Drori, Asaad Gammal, Alina Nemirovski, Rivka Hadar, Saja Baraghithy, Anna Permyakova, Matan Geron, Merav Cohen, Sabina Tsytkin-Kirschenzweig, Yael Riahi, Gil Leibowitz, Yaakov Nahmias, Avi Priel, Joseph Tam
Published in: Journal of the American Society of Nephrology, 2017, Page(s) ASN.2017040371, ISSN 1046-6673
DOI: 10.1681/ASN.2017040371

Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-Induced CKD

Author(s): Shiran Udi, Liad Hinden, Brian Earley, Adi Drori, Noa Reuveni, Rivka Hadar, Resat Cinar, Alina Nemirovski, Joseph Tam
Published in: Journal of the American Society of Nephrology, 2017, Page(s) ASN.2016101085, ISSN 1046-6673
DOI: 10.1681/ASN.2016101085

In Vivo Anticancer Activity of a Nontoxic Inert Phenolato Titanium Complex: High Efficacy on Solid Tumors Alone and Combined with Platinum Drugs

Author(s): Nitzan Ganot, Ori Briaitbard, Asaad Gammal, Joseph Tam, Jacob Hochman, Edit Y. Tshuva
Published in: ChemMedChem, 2018, ISSN 1860-7179
DOI: 10.1002/cmdc.201800551

Cannabinoid-1 receptor regulates mitochondrial dynamics and function in renal proximal tubular cells

Author(s): Adi Drori, Anna Permyakova, Rivka Hadar, Shiran Udi, Alina Nemirovski, Joseph Tam
Published in: Diabetes, Obesity and Metabolism, 2018, ISSN 1462-8902
DOI: 10.1111/dom.13497

The therapeutic potential of targeting the peripheral endocannabinoid/CB 1 receptor system

Author(s): Joseph Tam, Liad Hinden, Adi Drori, Shiran Udi, Shahar Azar, Saja Baraghithy
Published in: European Journal of Internal Medicine, Issue 49, 2018, Page(s) 23-29, ISSN 0953-6205
DOI: 10.1016/j.ejim.2018.01.009